{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:28:00Z","timestamp":1790285280312,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bja.2025.11.006","type":"journal-article","created":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T01:32:49Z","timestamp":1767231169000},"page":"653-661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["European Malignant Hyperthermia Group 2025 guidelines for the investigation of malignant hyperthermia susceptibility"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6475-3044","authenticated-orcid":false,"given":"Henrik","family":"R\u00fcffert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5057-0349","authenticated-orcid":false,"given":"Robyn","family":"Gillies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8127-1739","authenticated-orcid":false,"given":"Philip M.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4742-9352","authenticated-orcid":false,"given":"Klaus P.E.","family":"Glahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1749-1681","authenticated-orcid":false,"given":"Stephan","family":"Johannsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6480-1892","authenticated-orcid":false,"given":"Erik-Jan","family":"Kamsteeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4455-6401","authenticated-orcid":false,"given":"Anna","family":"Hellblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5574-7211","authenticated-orcid":false,"given":"Kathryn","family":"Stowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4222-2117","authenticated-orcid":false,"given":"Jonathan","family":"Bilmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7590-0252","authenticated-orcid":false,"given":"Martina","family":"Klincova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8641-4006","authenticated-orcid":false,"given":"Thierry","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Bandschapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.K.","family":"Bendixen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Bulger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.F.","family":"Dalmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Diaz-Cambronero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Glauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Islander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Michalek-Sauberer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Riazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"\u0160t\u011bp\u00e1nkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Tegazzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Urwyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2025.11.006_bib1","unstructured":"European Malignant Hyperthermia Group. Available from https:\/\/www.emhg.org\/ (accessed 25 November 2025). (Pubmed 2 December 2025), PMID: 6487446 https:\/\/doi.org\/10.1093\/bja\/56.11.1267; 1984 Nov"},{"key":"10.1016\/j.bja.2025.11.006_bib2","first-page":"1267","article-title":"The European Malignant Hyperpyrexia Group","volume":"56","year":"1984","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.11.006_bib3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00000542-199404000-00008","article-title":"A clinical grading scale to predict malignant hyperthermia susceptibility","volume":"80","author":"Larach","year":"1994","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.11.006_bib4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1399-6576.1997.tb04820.x","article-title":"In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group","volume":"41","author":"\u00d8rding","year":"1997","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.bja.2025.11.006_bib5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/bja\/aev225","article-title":"European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility","volume":"115","author":"Hopkins","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.11.006_bib6","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/343562a0","article-title":"Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2","volume":"343","author":"McCarthy","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bja.2025.11.006_bib7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/343559a0","article-title":"Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia","volume":"343","author":"MacLennan","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bja.2025.11.006_bib8","first-page":"1334","article-title":"Discordance, in a malignant hyperthermia pedigree, between in vitro contracture-test phenotypes and haplotypes for the MHS1 region on chromosome 19q12-13.2, comprising the C1840T transition in the RYR1 gene","volume":"56","author":"Deufel","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bja.2025.11.006_bib9","first-page":"833","article-title":"The G1021A substitution in the RYR1 gene does not cosegregate with malignant hyperthermia susceptibility in a British pedigree","volume":"60","author":"Adeokun","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bja.2025.11.006_bib10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1469-1809.2000.6440307.x","article-title":"Multiple interacting gene products may influence susceptibility to malignant hyperthermia","volume":"64","author":"Robinson","year":"2000","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.bja.2025.11.006_bib11","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1086\/515454","article-title":"Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle","volume":"60","author":"Monnier","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bja.2025.11.006_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00439-002-0864-6","article-title":"Several interacting genes influence the malignant hyperthermia phenotype","volume":"112","author":"Robinson","year":"2003","journal-title":"Hum Genet"},{"key":"10.1016\/j.bja.2025.11.006_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/bja\/86.2.283","article-title":"Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia","volume":"86","author":"Urwyler","year":"2001","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.11.006_bib14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/bjsm.2006.032516","article-title":"Is there a link between malignant hyperthermia and exertional heat illness?","volume":"41","author":"Hopkins","year":"2007","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.bja.2025.11.006_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00000542-200101000-00019","article-title":"Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis","volume":"94","author":"Wappler","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.11.006_bib16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.nmd.2013.03.008","article-title":"Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis","volume":"23","author":"Dlamini","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.bja.2025.11.006_bib17","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1213\/ANE.0b013e3181b5ae2d","article-title":"Core myopathies and risk of malignant hyperthermia","volume":"109","author":"Klingler","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2025.11.006_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13023-020-01384-x","article-title":"Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990\u20132019","volume":"15","author":"Lawal","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.bja.2025.11.006_bib19","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/humu.23635","article-title":"STAC3 variants cause a congenital myopathy with distinctive dysmorphic features and malignant hyperthermia susceptibility","volume":"39","author":"Zaharieva","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/j.bja.2025.11.006_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bja.2023.04.014","article-title":"What is malignant hyperthermia susceptibility?","volume":"131","author":"Hopkins","year":"2023","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.11.006_bib21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/sj.ejhg.5200964","article-title":"Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing?","volume":"11","author":"Robinson","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.bja.2025.11.006_bib22","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/bja\/aep204","article-title":"Genetic variation in RYR1 and malignant hyperthermia phenotypes","volume":"103","author":"Carpenter","year":"2009","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.11.006_bib23","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00000542-200211000-00007","article-title":"Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility","volume":"97","author":"Monnier","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.11.006_bib24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.bja.2025.11.006_bib25","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41436-021-01125-w","article-title":"Variant Curation Expert Panel recommendations for RYR1 pathogenicity classifications in malignant hyperthermia susceptibility","volume":"23","author":"Johnston","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.bja.2025.11.006_bib26","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1093\/hmg\/ddac145","article-title":"Updated Variant Curation Expert Panel criteria and pathogenicity classifications for 251 variants for RYR1-related malignant hyperthermia susceptibility","volume":"31","author":"Johnston","year":"2022","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bja.2025.11.006_bib27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.nmd.2014.10.008","article-title":"RYR1-related malignant hyperthermia with marked cerebellar involvement \u2013 a paradigm of heat-induced CNS injury?","volume":"25","author":"Forrest","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.bja.2025.11.006_bib28","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1074\/jbc.274.2.693","article-title":"Measurement of resting cytosolic Ca2+ concentrations and Ca2+ store size in HEK-293 cells transfected with malignant hyperthermia or central core disease mutant Ca2+ release channels","volume":"274","author":"Tong","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bja.2025.11.006_bib29","doi-asserted-by":"crossref","first-page":"25722","DOI":"10.1074\/jbc.M302165200","article-title":"Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling","volume":"278","author":"Yang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bja.2025.11.006_bib30","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/humu.21441","article-title":"A SImplified method for Segregation Analysis (SISA) to determine penetrance and expression of a genetic variant in a family","volume":"32","author":"M\u00f8ller","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1016\/j.bja.2025.11.006_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-2-21","article-title":"Malignant hyperthermia","volume":"2","author":"Rosenberg","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.bja.2025.11.006_bib32","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/ALN.0000000000003547","article-title":"Genomic screening for malignant hyperthermia susceptibility","volume":"133","author":"Biesecker","year":"2020","journal-title":"Anesthesiology"}],"updated-by":[{"DOI":"10.1016\/j.bja.2026.06.048","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000}},{"DOI":"10.1016\/j.bja.2026.06.048","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000}}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091225007974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091225007974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T16:42:03Z","timestamp":1779813723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091225007974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0007091225007974"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2025.11.006","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"European Malignant Hyperthermia Group 2025 guidelines for the investigation of malignant hyperthermia susceptibility","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2025.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}